NORMAL

Home
World ▾
Categories
- United States
- Europe
- Asia
- Middle East
Uganda election result: Yoweri Museveni beats Bobi Wine to win a seventh term - BBC

Super Admin •Feb 10, 2026
Politics ▾
Categories
Choose a category to explore related stories.
Business ▾
Categories
- Markets
- Economy
- Startups
- Finance
Choose a category to explore related stories.
Technology ▾
Categories
Choose a category to explore related stories.
Science ▾
Categories
- Space
- Health
- Environment
Choose a category to explore related stories.
Sports ▾
Categories
Choose a category to explore related stories.
Culture ▾
Categories
- Arts
- Music
- Film
- Travel
Choose a category to explore related stories.
Opinion

LazyNews Desk October 3, 2026 Technology

Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s - CNBC

Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.

The next generation of blockbuster obesity drugs isn't trying to replace GLP-1 medicines. Instead, drugmakers are developing treatments that can complement existing drugs and push weight loss furthe… [+7091 chars]

Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s - CNBC

Comments